CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

GDUFA IV: Fiscal Years 2028 – 2032

RegulatoryNeutral
AI Analysis

Summary

FDA announces preparation for the fourth reauthorization of GDUFA (Generic Drug User Fee Amendment) covering fiscal years 2028-2032, with details to be released as available.

Importance:2/10
Sentiment:
0.00
GDUFAFDAReauthorizationGeneric Drug User Fee

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 10, 2026 1:48 PM

Read Original